UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000004649
Receipt number R000005540
Scientific Title Reviewing of the bowel preparation for Colon Capsule Endoscopy (Further Work)
Date of disclosure of the study information 2010/12/01
Last modified on 2012/01/30 10:07:04

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Reviewing of the bowel preparation for Colon Capsule Endoscopy (Further Work)

Acronym

C1 Prep Add

Scientific Title

Reviewing of the bowel preparation for Colon Capsule Endoscopy (Further Work)

Scientific Title:Acronym

C1 Prep Add

Region

Japan


Condition

Condition

Subjects who undergo Colon Capsule Endoscopy

Classification by specialty

Gastroenterology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Clarify whether Japanese specific 1- day colon preparation method can obtain as high anus excretion rate as the oversea methods

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

Anus excretion rate

Key secondary outcomes

Colon cleansing level


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Diagnosis

Type of intervention

Medicine

Interventions/Control_1

Conduct a modified version of the Japan original 1 day bowel preparation method (Moisture load (Laxative): 3.8L, administration of laxative only on the test day, no breakfast on the test day only). Modifications include 1. 5 walking sessions between 5-10 minutes during procedure, 2. Ingest Capsule 2 hour earlier (the time changed from 12:00 PM to 10:00 AM, 3. Reduce an amount of intake of Dimethicone, and 4. Obligatory administration of suppository, 5. In case of unexcreation of capsule, additionally booster 3, 4 are prescribed with light meal.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

40 years-old <=

Age-upper limit

79 years-old >=

Gender

Male and Female

Key inclusion criteria

Subjects are between 40 - 79 years of age and have planned to undergo Colonoscopy.

Key exclusion criteria

1) Subjects who have a swallowing disorder
2) Subjects who have a history of allergic reaction to the following medicines (1 - 6) used in this study. These medicines are used normally in the clinical situations in Japan.
1. Polyethylene glycol 2. Magnesium citrate solution 3. Mosapride citrate 4. Dimethicone, Pronase, Sodium bicarbonate 5. Bisacodyl 6. Glycelin
3) Subjects who are pregnant
4) Subjects who have a cardiac pacemaker implanted or other medical electronic devices applied in the body
5) Subjects who have a suspected symptom or who have a history of intestinal obstruction or intestinal stenosis
6) Subjects who have a history of radiotherapy
7) Subjects who have Crohn's disease
or ulcerative colitis
8) Other cases where doctors consider it inappropriate

Target sample size

25


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yutaka Saito MD, PhD

Organization

National Cancer Center Hospital

Division name

Division of Endoscopy

Zip code


Address

5-1-1 Tsukiji, Chuo-ku, Tokyo

TEL

03-3542-2511

Email



Public contact

Name of contact person

1st name
Middle name
Last name Yasuo Kakugawa MD

Organization

National Cancer Center, Research Center for Cancer Prevention and Screening

Division name

Screening Technology and Development Division

Zip code


Address

5-1-1 Tsukiji, Chuo-ku, Tokyo

TEL

03-3542-2511

Homepage URL


Email



Sponsor or person

Institute

National Cancer Center Hospital

Institute

Department

Personal name



Funding Source

Organization

Ministry of Health, Labour and Welfare, Japan

Organization

Division

Category of Funding Organization

Nationality of Funding Organization



Other related organizations

Co-sponsor

Jikei University

Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

国立がん研究センター(東京都)、東京慈恵会医科大学(東京都)


Other administrative information

Date of disclosure of the study information

2010 Year 12 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2010 Year 10 Month 08 Day

Date of IRB


Anticipated trial start date

2010 Year 10 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2010 Year 12 Month 01 Day

Last modified on

2012 Year 01 Month 30 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000005540


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name